Delusional disorder, somatic subtype, treated with fluvoxamine

Z. Kaplan, P. Lichtenberg

    Research output: Contribution to journalArticlepeer-review

    2 Scopus citations

    Abstract

    Dysmorphophobia, a brief and exaggerated concern with an imagined or negligible defect in physical appearance, has been divided by DSM-IV into two separate disorders. When the disturbance attains delusional intensity the proper diagnosis is delusional disorder of the somatic subtype. For the non-delusional cases, DSM-IV created the category of BodyDystnorphic Disorder (BDD). Two cases of delusianal disorder, somatic subtype, are described which were successfully treated with fluvoxamine. The validity of this DSM-IV diagnostic entity is thus questioned.

    Original languageEnglish
    Pages (from-to)238-241
    Number of pages4
    JournalEuropean Journal of Psychiatry
    Volume9
    Issue number4
    StatePublished - 1 Jan 1995

    Keywords

    • Delusion
    • Fluvoxamine psychopharmacology

    Fingerprint

    Dive into the research topics of 'Delusional disorder, somatic subtype, treated with fluvoxamine'. Together they form a unique fingerprint.

    Cite this